- You should not be treated with Promacta® if you have myelodysplastic syndromes (MDS)
- The risk of getting a blood clot increases with Promacta® treatment
- Treatment with Promacta® may lead to new or worsened cataracts, tell your doctor if your eyesight is affected during treatment
- Before starting treatment, tell your doctor if you have liver or bleeding problems, history of cataracts or blood clots, a blood cancer, or had a splenectomy
- It’s not known if Promacta® can cause harm to unborn babies, patients should not get pregnant or breast feed while taking it
- Tell your doctor about any medicines or supplements you’re taking to avoid interactions, especially statins and anticoagulants
- Patients should avoid drugs and activities that may increase their risk of bleeding
Please refer to the manufacturer‘s website to learn all the information needed to use this medicine safely and effectively.
Reviews
There are no reviews yet.